September 23, 2017 11:45 AM ET

Biotechnology

Company Overview of Novopyxis Inc.

Company Overview

Novopyxis Inc., a biotechnology company, develops novel anti-inflammatory therapeutics and interventions. It focuses on treatment for neurological and metabolic conditions which result from complications related to inflammatory issues ranging from ALS to cystic fibrosis and more. The company was founded in 2013 and is based in Boston, Massachusetts.

41 Winter Street

4th Floor

Boston, MA 02108

United States

Founded in 2013

Phone:

857-239-8504

Key Executives for Novopyxis Inc.

Novopyxis Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3Bar Biologics Inc. United States

Recent Private Companies Transactions

Type
Date
Target
Private Placement
April 24, 2017
--
\
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Tax Management Inc United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Novopyxis Inc., please visit www.novopyxis.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.